Research News

Immune pathway upregulation and lower genomic instability distinguish EBVpositive nodal T/NK-cell lymphoma from ENKTL and PTCL-NOS

Primary Epstein-Barr virus (EBV)-positive nodal T/NK-cell lymphoma (PTCL-EBV) is an aggressive and poorly understood disease that occurs mostly in East Asia. In this collaborative study, led by A/Prof Ng Siok Bian and Dr Jason Pitt, the authors and their team characterise PTCL-EBV as an aggressive lymphoma with minimal genomic instability, immune-related gene expression and activation of NFκB along with its associated genes. These findings afford both novel insight into the pathogenesis of this disease and highlight new potential targets for therapeutic development.

Read more: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335103/

Share this story:
Facebook
Twitter
LinkedIn

Related Research News

Research News

Genetic Testing in Asian Cancer Patients: Early Detection and Prevention

Multiple primary cancers (MPC) often indicate a hereditary cancer predisposition syndrome. In a study led by Prof Lee Soo Chin, …

Read More →
Research News

Predicting CLL Treatment with BCL-2 Dependence

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow, leading to the buildup …

Read More →
Research News

One Month of Brief Weekly Magnetic Field Therapy Enhances the Anticancer Potential of Female Human Sera

Muscle is our first line of defence against cancer. A randomised clinical trial in Singapore, led by N2CR members A/Prof …

Read More →